NCT04573881View on ClinicalTrials.gov

The HistoSonics System for Treatment of Primary and Metastatic Liver Tumors Using Histotripsy (#HOPE4LIVER EU/UK)

NAActive, not recruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 4, 2021

Primary Completion Date

September 29, 2022

Study Completion Date

August 31, 2027

Conditions
Liver NeoplasmsHepatocellular CarcinomaLiver Metastases
Interventions
DEVICE

HistoSonics System

The HistoSonics System - intended for the destruction of liver tissue using histotripsy, a non-thermal, mechanical process using focused ultrasound.

Trial Locations (6)

39120

Universitätsklinikum Magdeburg Klinik für Radiologie und Nuklearmedizin, Magdeburg

Unknown

Städtisches Klinikum Braunschweig gGmbH, Braunschweig

Istituto Clinico Humanitas - Humanitas Mirasole S.P.A., Milan

Vall d'Hebron, Barcelona

LS9 7TF

Leeds Teaching Hospitals NHS Trust, Leeds

NE7 7DN

The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle

Sponsors

Lead Sponsor

HistoSonics, Inc.
All Listed Sponsors
lead

HistoSonics, Inc.

INDUSTRY

NCT04573881 - The HistoSonics System for Treatment of Primary and Metastatic Liver Tumors Using Histotripsy (#HOPE4LIVER EU/UK) | Biotech Hunter | Biotech Hunter